Mendonça-Rivera MA, Berni-Betancourt A, Cárdenas IC, Escobar J, Hardy C

Idioma: Inglés [English version]
Referencias bibliográficas: 10
Paginas: s477-479
Archivo PDF: 170.19 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Zhang J, Johnsen SP, Guo Y, Lip GYH. Epidemiology of atrial fibrillation: Geographic/ecological risk factors, age, sex, genetics. Card Electrophysiol Clin. 2021; 13: 1-23.

2. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2020; 40: 373-498.

3. Ariyaratnam JP, Lau DH, Sanders P, Kalman JM. Atrial fibrillation and heart failure: epidemiology, pathophysiology, prognosis, and management. Card Electrophysiol Clin. 2021; 13: 47-62.

4. Kirchhof P, Camm J, Goette A, Brandes A, Eckardt L, Elvan A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020; 383: 1305-1316.

5. Piccini JP, Simon DN, Steinberg BA, Thomas L, Allen LA, Fonarow GC et al. Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-year results from the ORBIT-AF registry JAMA Cardiol. 2016; 1: 282-291.

6. Russo AM, Zeitler EP, Giczewska A, Silverstein AP, Al-Khalidi HR, Cha YM et al. Association between sex and treatment outcomes of atrial fibrillation ablation versus drug therapy: results from the CABANA trial. Circulation. 2021; 143: 661-672.

7. Linde C, Bongiorni MG, Birgersdotter-Green U, Curtis AB, Deisenhofer I, Furokawa T et al. Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society. Europace. 2018; 20: 1565-1565ao.

8. Nielsen PB, Skjoth F, Overvad TF, Larsen TB, Lip GY. Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: should we use a CHA2DS2-VA score rather than CHA2DS2-VASc? Circulation. 2018; 137: 832-840.

9. Westerman S, Wenger N. Gender differences in atrial fibrillation: a review of epidemiology, management, and outcomes. Curr Cardiol Rev. 2019; 15: 136-144.

10. Kuck KH, Brugada J, Furnkran A, Chun KJ, Metzner A, Ouyang F et al. Impact of female sex on clinical outcomes in the FIRE AND ICE trial of catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol. 2018; 11: e006204.